ADD CONDITION

items per page

Blue-Emu Lidocaine Pain Relief Cream

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 40 mg
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2017
Label revision date
September 9, 2025
Active ingredient
Lidocaine Hydrochloride 40 mg
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2017
Label revision date
September 9, 2025
Manufacturer
Kingsway Pharmaceuticals dba NFI, LLC
Registration number
M017
NDC root
69993-350

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

BLUE-EMU® is a nerve desensitizing pain relief cream designed to provide fast-acting relief from minor pain. It contains lidocaine, a medication that helps numb the area to reduce discomfort, and emu oil, which is known for its soothing properties. This cream is marketed as America’s #1 emu oil formula and is odor-free, making it a convenient option for those seeking pain relief without strong scents.

The cream features a hands-free application method with a soft sponge applicator, allowing for easy and effective use. With its new easy open cap design, you can quickly access the product whenever you need it.

Uses

You can use this medication to temporarily relieve minor pain. It’s designed to help you feel more comfortable when dealing with everyday aches and discomforts. Rest assured, there are no known teratogenic effects (which means it doesn’t cause birth defects) associated with this medication, making it a safer option for those who may be concerned about such risks.

Dosage and Administration

If you are an adult or a child over 12 years old, you should apply a thin layer of the medication to the affected area every 6 to 8 hours. However, make sure not to exceed three applications within a 24-hour period. This helps ensure that you are using the medication safely and effectively.

If you have a child who is 12 years old or younger, it’s important to consult a doctor before using this medication. They can provide guidance on the appropriate treatment for younger children. Always follow your healthcare provider's instructions for the best results.

What to Avoid

You should avoid using this medication on large areas of your body or on any cut, irritated, or damaged skin, as well as on puncture wounds. It's important not to use it for more than one week without consulting your doctor. Additionally, make sure to keep it away from your eyes, and do not cover the treated area with bandages or apply local heat, such as heating pads. Following these guidelines will help ensure your safety and the effectiveness of the treatment.

Side Effects

When using this product, it's important to be aware of some potential side effects and precautions. You should only apply it to the skin and avoid using it on large areas, cut or damaged skin, or puncture wounds. If you experience worsening symptoms or if your condition does not improve after a week, consult a doctor. Additionally, avoid contact with your eyes and do not apply heat or bandage the area where the product is used.

If you are pregnant or breastfeeding, it's best to consult a healthcare professional before using this product. Keep it out of reach of children, and if swallowed, seek medical help or contact Poison Control immediately.

Warnings and Precautions

This product is for external use only, so please avoid applying it to large areas of your body or on any cut, irritated, or damaged skin. It should not be used on puncture wounds, and you should not use it for more than one week without consulting your doctor. Always follow the directions on the packaging carefully, and be sure to keep it away from your eyes. Additionally, do not cover the treated area with bandages or apply heat, such as heating pads.

If your condition worsens, or if your symptoms last longer than seven days or return after clearing up, stop using the product and contact your doctor. Keep this product out of reach of children, and if it is swallowed, seek medical help or contact Poison Control Center immediately.

Overdose

It's important to keep this medication out of reach of children and pets. If someone accidentally swallows it, you should seek medical help immediately or contact the Poison Control Center.

Signs of an overdose can vary, but if you suspect that an overdose has occurred, do not hesitate to get help. Acting quickly can make a significant difference in ensuring safety and health. Always prioritize reaching out for professional assistance in these situations.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If your child is 12 years old or younger, it's important to consult with a doctor before using this medication. For those over 12, you can apply a thin layer to the affected area every 6 to 8 hours, but be sure not to exceed three applications in a 24-hour period.

Always keep this medication out of reach of children and pets. If it is swallowed, seek medical help or contact the Poison Control Center immediately.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or safety considerations for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have renal impairment (kidney issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your health situation. They can help monitor your kidney function and make any necessary adjustments to your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Before starting any new medication, including this one, you should discuss your liver health with your healthcare provider. They can help determine the best approach for your treatment and ensure your safety.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any health conditions you have to receive the best care possible.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 68-77°F (20-25°C). This temperature range helps maintain the integrity and effectiveness of the device.

When handling the product, be sure to do so with clean hands and in a sterile field (a clean area free from germs) to prevent contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

No further information is available.

FAQ

What is BLUE-EMU®?

BLUE-EMU® is a nerve desensitizing pain relief cream that contains Lidocaine for pain relief and Emu Oil.

How do I use BLUE-EMU®?

Apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 applications in a 24-hour period for adults and children over 12 years.

Are there any precautions for using BLUE-EMU®?

Do not use on large areas of the body, on cut or damaged skin, or for more than one week without consulting a doctor. Avoid contact with eyes.

What should I do if my condition worsens while using BLUE-EMU®?

Stop use and ask a doctor if your condition worsens or if symptoms persist for more than 7 days.

Can I use BLUE-EMU® if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, ask a health professional before use.

What should I do if BLUE-EMU® is swallowed?

If swallowed, get medical help or contact Poison Control Center right away.

What are the storage conditions for BLUE-EMU®?

Store BLUE-EMU® at 68-77°F (20-25°C).

Is BLUE-EMU® odor-free?

Yes, BLUE-EMU® is fast acting and odor free.

Packaging Info

Below are the non-prescription pack sizes of Blue-Emu Lidocaine Pain Relief Cream (lidocaine cream 4%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blue-Emu Lidocaine Pain Relief Cream.
Details

Drug Information (PDF)

This file contains official product information for Blue-Emu Lidocaine Pain Relief Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area every 6 to 8 hours. The total number of applications must not exceed 3 times within a 24-hour period.

For children 12 years of age or younger, it is advised to consult a physician before use.

Contraindications

Use is contraindicated in the following situations:

Application on large areas of the body or on cut, irritated, or damaged skin is prohibited due to the potential for increased systemic absorption and adverse effects. The product should not be applied to puncture wounds, as this may lead to complications or infection. Prolonged use beyond one week without consulting a healthcare professional is contraindicated to prevent potential adverse reactions. Additionally, contact with the eyes must be avoided to prevent irritation or injury. Bandaging or applying local heat, such as heating pads, to the area of use is also contraindicated, as this may enhance absorption and increase the risk of side effects.

Warnings and Precautions

For external use only. This product is contraindicated for application on large areas of the body, as well as on cut, irritated, or damaged skin. It should not be used on puncture wounds. Prolonged use beyond one week is not recommended without prior consultation with a healthcare professional.

When utilizing this product, it is imperative to adhere strictly to the provided directions. Users must read and follow all instructions and warnings indicated on the packaging. Care should be taken to avoid contact with the eyes. Additionally, the area of application should not be bandaged or subjected to local heat, such as heating pads.

If the condition worsens or if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days, the user should discontinue use and seek medical advice.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for application on large areas of the body, on cut, irritated, or damaged skin, and on puncture wounds. The product should not be used for more than one week without consulting a healthcare professional.

During use, patients should avoid contact with the eyes and should not bandage or apply local heat, such as heating pads, to the area of application. If the condition worsens, or if symptoms persist for more than seven days or resolve and then recur within a few days, patients are advised to discontinue use and consult a doctor.

For pregnant or breastfeeding individuals, it is recommended to seek advice from a healthcare professional prior to use. Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or the Poison Control Center should be contacted.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Blue-Emu Lidocaine Pain Relief Cream (lidocaine cream 4%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blue-Emu Lidocaine Pain Relief Cream.
Details

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. For patients over 12 years, the recommended dosage is to apply a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications within a 24-hour period.

It is important to keep this medication out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought, or contact the Poison Control Center.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children and pets to prevent accidental ingestion. Should ingestion occur, immediate medical assistance is required. Healthcare professionals should advise patients or caregivers to contact the Poison Control Center without delay.

Prompt action is crucial in managing potential overdosage situations. Symptoms may vary depending on the substance involved, and healthcare providers should be prepared to assess and address any adverse effects that may arise. It is essential to follow established protocols for the management of overdosage, which may include supportive care and symptomatic treatment as necessary.

Nonclinical Toxicology

There is currently no available information regarding teratogenic effects, non-teratogenic effects, or any specific findings in nonclinical toxicology studies. Additionally, no data has been provided concerning animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and pets to prevent accidental ingestion or exposure. Instruct patients that if the product is swallowed, they should seek medical help or contact the Poison Control Center immediately.

It is essential for patients to use the product only as directed. They should be encouraged to read and follow all directions and warnings provided on the carton to ensure safe and effective use.

Healthcare providers should also inform patients to avoid contact with the eyes, as this may lead to irritation or injury. Additionally, patients should be cautioned against bandaging or applying local heat, such as heating pads, to the area of use, as this may exacerbate any potential side effects or complications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68-77°F (20-25°C) to maintain its integrity and efficacy. Proper storage conditions should be observed to ensure optimal performance and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Blue-Emu Lidocaine Pain Relief Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Blue-Emu Lidocaine Pain Relief Cream, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.